Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.441
Filter
1.
J R Soc Interface ; 21(216): 20240106, 2024 Jul.
Article in English | MEDLINE | ID: mdl-39045680

ABSTRACT

Lassa fever is a West African rodent-borne viral haemorrhagic fever that kills thousands of people a year, with 100 000 to 300 000 people a year probably infected by Lassa virus (LASV). The main reservoir of LASV is the Natal multimammate mouse, Mastomys natalensis. There is reported asynchrony between peak infection in the rodent population and peak Lassa fever risk among people, probably owing to differing seasonal contact rates. Here, we developed a susceptible-infected-recovered ([Formula: see text])-based model of LASV dynamics in its rodent host, M. natalensis, with a persistently infected class and seasonal birthing to test the impact of changes to seasonal birthing in the future owing to climate and land use change. Our simulations suggest shifting rodent birthing timing and synchrony will alter the peak of viral prevalence, changing risk to people, with viral dynamics mainly stable in adults and varying in the young, but with more infected individuals. We calculate the time-average basic reproductive number, [Formula: see text], for this infectious disease system with periodic changes to population sizes owing to birthing using a time-average method and with a sensitivity analysis show four key parameters: carrying capacity, adult mortality, the transmission parameter among adults and additional disease-induced mortality impact the maintenance of LASV in M. natalensis most, with carrying capacity and adult mortality potentially changeable owing to human activities and interventions.


Subject(s)
Lassa Fever , Lassa virus , Murinae , Animals , Lassa Fever/epidemiology , Lassa Fever/transmission , Lassa Fever/virology , Lassa virus/physiology , Murinae/virology , Humans , Models, Biological , Disease Reservoirs/virology , Africa, Western/epidemiology , Seasons , Female
2.
Viruses ; 16(7)2024 Jun 27.
Article in English | MEDLINE | ID: mdl-39066204

ABSTRACT

In recent years, the transmission of viruses from wildlife to humans has raised significant public health concerns, exemplified by the COVID-19 pandemic caused by the betacoronavirus SARS-CoV-2. Human activities play a substantial role in increasing the risk of zoonotic virus transmission from wildlife to humans. Rats and mice are prevalent in urban environments and may act as reservoirs for various pathogens. This study aimed to evaluate the presence of zoonotic viruses in wild rats and mice in both urban and rural areas, focusing on well-known zoonotic viruses such as betacoronavirus, hantavirus, arenavirus, kobuvirus, and monkeypox virus, along with other viruses occasionally detected in rats and mice, including rotavirus, norovirus, and astrovirus, which are known to infect humans at a high rate. A total of 128 animals were captured, including 70 brown rats (Rattus norvegicus), 45 black rats (Rattus rattus), and 13 house mice (Mus musculus), and feces, lung, and liver were collected. Among brown rats, one fecal sample tested positive for astrovirus RNA. Nucleotide sequencing revealed high sequence similarity to both human and rat astrovirus, suggesting co-presence of these viruses in the feces. Murine kobuvirus (MuKV) was detected in fecal samples from both black (n = 7) and brown (n = 6) rats, primarily from urban areas, as confirmed by sequence analysis. These findings highlight the importance of surveillance and research to understand and mitigate the risks associated with the potential transmission of pathogens by rodents.


Subject(s)
Feces , Zoonoses , Animals , Humans , Mice , Rats/virology , Feces/virology , Zoonoses/virology , Zoonoses/transmission , Phylogeny , COVID-19/virology , COVID-19/transmission , COVID-19/epidemiology , Viral Zoonoses/transmission , Viral Zoonoses/virology , Animals, Wild/virology , Disease Reservoirs/virology , Muridae/virology , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Viruses/classification , Viruses/isolation & purification , Viruses/genetics
3.
Viruses ; 16(7)2024 Jul 17.
Article in English | MEDLINE | ID: mdl-39066316

ABSTRACT

Hantaviruses are zoonotic agents responsible for causing Hantavirus Cardiopulmonary Syndrome (HCPS) in the Americas, with Brazil ranking first in number of confirmed HCPS cases in South America. In this study, we simulate the monthly spread of highly lethal hantavirus in natural hosts by conjugating a Kermack-McCormick SIR model with a cellular automata model (CA), therefore simultaneously evaluating both in-cell and between-cell infection dynamics in host populations, using recently compiled data on main host species abundances and confirmed deaths by hantavirus infection. For both host species, our models predict an increase in the area of infection, with 22 municipalities where no cases have been confirmed to date expected to have at least one case in the next decade, and a reduction in infection in 11 municipalities. Our findings support existing research and reveal new areas where hantavirus is likely to spread within recognized epicenters. Highlighting spatial-temporal trends and potential expansion, we emphasize the increased risk due to pervasive habitat fragmentation and agricultural expansion. Consistent prevention efforts and One Health actions are crucial, especially in newly identified high-risk municipalities.


Subject(s)
Hantavirus Infections , Orthohantavirus , Brazil/epidemiology , Animals , Hantavirus Infections/epidemiology , Hantavirus Infections/virology , Humans , Disease Reservoirs/virology , Hantavirus Pulmonary Syndrome/epidemiology , Hantavirus Pulmonary Syndrome/virology , Zoonoses/epidemiology , Zoonoses/virology
4.
Emerg Infect Dis ; 30(8): 1609-1620, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39043403

ABSTRACT

SARS-CoV-2 can infect wildlife, and SARS-CoV-2 variants of concern might expand into novel animal reservoirs, potentially by reverse zoonosis. White-tailed deer and mule deer of North America are the only deer species in which SARS-CoV-2 has been documented, raising the question of whether other reservoir species exist. We report cases of SARS-CoV-2 seropositivity in a fallow deer population located in Dublin, Ireland. Sampled deer were seronegative in 2020 when the Alpha variant was circulating in humans, 1 deer was seropositive for the Delta variant in 2021, and 12/21 (57%) sampled deer were seropositive for the Omicron variant in 2022, suggesting host tropism expansion as new variants emerged in humans. Omicron BA.1 was capable of infecting fallow deer lung type-2 pneumocytes and type-1-like pneumocytes or endothelial cells ex vivo. Ongoing surveillance to identify novel SARS-CoV-2 reservoirs is needed to prevent public health risks during human-animal interactions in periurban settings.


Subject(s)
COVID-19 , Deer , SARS-CoV-2 , Animals , SARS-CoV-2/immunology , SARS-CoV-2/genetics , COVID-19/epidemiology , COVID-19/veterinary , Humans , Deer/virology , Ireland/epidemiology , Seroepidemiologic Studies , Urban Population , Disease Reservoirs/virology , Disease Reservoirs/veterinary , Animals, Wild/virology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Female , Male
5.
Vopr Virusol ; 69(3): 255-265, 2024 Jul 05.
Article in English | MEDLINE | ID: mdl-38996374

ABSTRACT

INTRODUCTION: Bats are natural reservoirs of coronaviruses (Coronaviridae), which have caused three outbreaks of human disease SARS, MERS and COVID-19 or SARS-2 over the past decade. The purpose of the work is to study the diversity of coronaviruses among bats inhabiting the foothills and mountainous areas of the Republics of Dagestan, Altai and the Kemerovo region. MATERIALS AND METHODS: Samples of bat oral swabs and feces were tested for the presence of coronavirus RNA by reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: It has been shown that the greater horseshoe bats (Rhinolophus ferrumequinum), inhabiting the Republic of Dagestan, are carriers of two different coronaviruses. One of the two coronaviruses is a member of the Sarbecovius subgenus of the Betacoronavirus genus, which includes the causative agents of SARS and COVID-19. The second coronavirus is assigned to the Decacovirus subgenus of the Alphacoronavirus genus and is most similar to viruses identified among Rhinolophus spp. from European and Middle Eastern countries. In the Altai Republic and Kemerovo region, coronaviruses belonging to the genus Alphacoronavirus, subgenus Pedacovirus, were found in the smooth-nosed bats: Ikonnikov`s bat (Myotis ikonnikovi) and the eastern bat (Myotis petax). The virus from the Altai Republic from M. ikonnikovi is close to viruses from Japan and Korea, as well as viruses from Myotis spp. from European countries. The virus from the Kemerovo region from M. petax groups with coronaviruses from Myotis spp. from Asian countries and is significantly different from coronaviruses previously discovered in the same natural host.


Subject(s)
Chiroptera , Animals , Chiroptera/virology , Siberia/epidemiology , Phylogeny , Disease Reservoirs/virology , Coronavirus/genetics , Coronavirus/isolation & purification , Coronavirus/classification , Humans , Feces/virology , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , COVID-19/virology , COVID-19/epidemiology , COVID-19/veterinary , Coronavirus Infections/virology , Coronavirus Infections/veterinary , Coronavirus Infections/epidemiology
6.
Virol J ; 21(1): 146, 2024 Jun 25.
Article in English | MEDLINE | ID: mdl-38918816

ABSTRACT

The genus Jeilongvirus comprises non-segmented negative-stranded RNA viruses that are classified within the Paramyxoviridae family by phylogeny. Jeilongviruses are found in various reservoirs, including rodents and bats. Rodents are typical viral reservoirs with diverse spectra and zoonotic potential. Little is currently known about jeilongviruses in rodents from central China. The study utilized high-throughput and Sanger sequencing to obtain jeilongvirus genomes, including those of two novel strains (HBJZ120/CHN/2021 (17,468 nt) and HBJZ157/CHN/2021 (19,143 nt)) and three known viruses (HBXN18/CHN/2021 (19,212 nt), HBJZ10/CHN/2021 (19,700 nt), HBJM106/CHN/2021 (18,871 nt)), which were characterized by genome structure, identity matrix, and phylogenetic analysis. Jeilongviruses were classified into three subclades based on their topology, phylogeny, and hosts. Based on the amino acid sequence identities and phylogenetic analysis of the L protein, HBJZ120/CHN/2021 and HBJZ157/CHN/2021 were found to be strains rather than novel species. Additionally, according to specific polymerase chain reaction screening, the positive percentage of Beilong virus in Hubei was 6.38%, suggesting that Beilong virus, belonging to the Jeilongvirus genus, is likely to be widespread in wild rodents. The identification of novel strains further elucidated the genomic diversity of jeilongviruses. Additionally, the prevalence of jeilongviruses in Hubei, China, was profiled, establishing a foundation for the surveillance and early warning of emerging paramyxoviruses.


Subject(s)
Genome, Viral , Phylogeny , Rodentia , Animals , China , Rodentia/virology , Animals, Wild/virology , Paramyxovirinae/genetics , Paramyxovirinae/classification , Paramyxovirinae/isolation & purification , RNA, Viral/genetics , Paramyxoviridae Infections/veterinary , Paramyxoviridae Infections/virology , Paramyxoviridae Infections/epidemiology , High-Throughput Nucleotide Sequencing , Disease Reservoirs/virology , Sequence Analysis, DNA
7.
Emerg Infect Dis ; 30(7): 1454-1458, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38916725

ABSTRACT

Few cases of hantavirus pulmonary syndrome have been reported in northeastern Argentina. However, neighboring areas show a higher incidence, suggesting underreporting. We evaluated the presence of antibodies against orthohantavirus in small rodents throughout Misiones province. Infected Akodon affinis montensis and Oligoryzomys nigripes native rodents were found in protected areas of Misiones.


Subject(s)
Antibodies, Viral , Orthohantavirus , Animals , Argentina/epidemiology , Orthohantavirus/immunology , Orthohantavirus/classification , Orthohantavirus/isolation & purification , Antibodies, Viral/blood , Hantavirus Infections/epidemiology , Hantavirus Infections/veterinary , Hantavirus Infections/virology , Rodentia/virology , Rodent Diseases/epidemiology , Rodent Diseases/virology , Humans , Hantavirus Pulmonary Syndrome/epidemiology , Disease Reservoirs/virology
8.
Poult Sci ; 103(8): 103940, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38909506

ABSTRACT

Migratory wild birds can carry various pathogens, such as influenza A virus, which can spread to globally and cause disease outbreaks and epidemics. Continuous epidemiological surveillance of migratory wild birds is of great significance for the early warning, prevention, and control of epidemics. To investigate the pathogen infection status of migratory wild birds in eastern China, fecal samples were collected from wetlands to conduct pathogen surveillance. The results showed that duck orthoreovirus (DRV) and goose parvovirus (GPV) nucleic acid were detected positive in the fecal samples collected from wild ducks, egrets, and swan. Phylogenetic analysis of the amplified viral genes reveals that the isolates were closely related to the prevalent strains in the regions involved in East Asian-Australasian (EAA) migratory flyway. Phylogenetic analysis of the amplified viral genes confirmed that they were closely related to circulating strains in the regions involved in the EAA migration pathway. The findings of this study have expanded the host range of the orthoreovirus and parvovirus, and revealed possible virus transmission between wild migratory birds and poultry.


Subject(s)
Animals, Wild , Bird Diseases , Orthoreovirus, Avian , Parvoviridae Infections , Parvovirus , Phylogeny , Reoviridae Infections , Animals , Reoviridae Infections/veterinary , Reoviridae Infections/epidemiology , Reoviridae Infections/virology , Orthoreovirus, Avian/isolation & purification , Orthoreovirus, Avian/genetics , Parvoviridae Infections/veterinary , Parvoviridae Infections/virology , Parvoviridae Infections/epidemiology , China/epidemiology , Bird Diseases/virology , Bird Diseases/epidemiology , Animals, Wild/virology , Parvovirus/genetics , Parvovirus/isolation & purification , Feces/virology , Disease Reservoirs/veterinary , Disease Reservoirs/virology , Ducks/virology , Anseriformes/virology , Epidemiological Monitoring/veterinary
9.
Adv Exp Med Biol ; 1451: 75-90, 2024.
Article in English | MEDLINE | ID: mdl-38801572

ABSTRACT

The current multicounty outbreak of monkeypox virus (MPXV) posed an emerging and continued challenge to already strained public healthcare sector, around the globe. Since its first identification, monkeypox disease (mpox) remained enzootic in Central and West African countries where reports of human cases are sporadically described. Recent trends in mpox spread outside the Africa have highlighted increased incidence of spillover of the MPXV from animal to humans. While nature of established animal reservoirs remained undefined, several small mammals including rodents, carnivores, lagomorphs, insectivores, non-human primates, domestic/farm animals, and several species of wildlife are proposed to be carrier of the MPXV infection. There are established records of animal-to-human (zoonotic) spread of MPXV through close interaction of humans with animals by eating bushmeat, contracting bodily fluids or trading possibly infected animals. In contrast, there are reports and increasing possibilities of human-to-animal (zooanthroponotic) spread of the MPXV through petting and close interaction with pet owners and animal care workers. We describe here the rationales and molecular factors which predispose the spread of MPXV not only amongst humans but also from animals to humans. A range of continuing opportunities for the spread and evolution of MPXV are discussed to consider risks beyond the currently identified groups. With the possibility of MPXV establishing itself in animal reservoirs, continued and broad surveillance, investigation into unconventional transmissions, and exploration of spillover events are warranted.


Subject(s)
Monkeypox virus , Mpox (monkeypox) , Zoonoses , Animals , Mpox (monkeypox)/transmission , Mpox (monkeypox)/epidemiology , Mpox (monkeypox)/virology , Humans , Monkeypox virus/pathogenicity , Monkeypox virus/genetics , Zoonoses/transmission , Zoonoses/virology , Zoonoses/epidemiology , Disease Reservoirs/virology , Disease Outbreaks , Animals, Wild/virology
10.
Methods Mol Biol ; 2807: 93-110, 2024.
Article in English | MEDLINE | ID: mdl-38743223

ABSTRACT

Correlative light-electron microscopy (CLEM) has evolved in the last decades, especially after significant developments in sample preparation, imaging acquisition, software, spatial resolution, and equipment, including confocal, live-cell, super-resolution, and electron microscopy (scanning, transmission, focused ion beam, and cryo-electron microscopy). However, the recent evolution of different laser-related techniques, such as mass spectrometry imaging (MSI) and laser capture microdissection, could further expand spatial imaging capabilities into high-resolution OMIC approaches such as proteomic, lipidomics, small molecule, and drug discovery. Here, we will describe a protocol to integrate the detection of rare viral reservoirs with imaging mass spectrometry.


Subject(s)
HIV Infections , Humans , HIV Infections/virology , HIV-1/physiology , Mass Spectrometry/methods , Microscopy, Electron/methods , Molecular Imaging/methods , Disease Reservoirs/virology
11.
Sci Rep ; 14(1): 11171, 2024 05 15.
Article in English | MEDLINE | ID: mdl-38750049

ABSTRACT

White-tailed deer (Odocoileus virginianus) have emerged as a reservoir host for SARS-CoV-2 given their susceptibility to infection and demonstrated high rates of seroprevalence and infection across the United States. As SARS-CoV-2 circulates within free-ranging white-tailed deer populations, there is the risk of transmission to other wildlife species and even back to the human population. The goal of this study was to determine the susceptibility, shedding, and immune response of North American elk (Cervus elaphus canadensis) to experimental infection with SARS-CoV-2, to determine if another wide-ranging cervid species could potentially serve as a reservoir host for the virus. Here we demonstrate that while North American elk do not develop clinical signs of disease, they do develop a neutralizing antibody response to infection, suggesting the virus is capable of replicating in this mammalian host. Additionally, we demonstrate SARS-CoV-2 RNA presence in the medial retropharyngeal lymph nodes of infected elk three weeks after experimental infection. Consistent with previous observations in humans, these data may highlight a mechanism of viral persistence for SARS-CoV-2 in elk.


Subject(s)
Antibodies, Neutralizing , Antibodies, Viral , COVID-19 , Deer , RNA, Viral , SARS-CoV-2 , Animals , Deer/virology , SARS-CoV-2/genetics , SARS-CoV-2/physiology , COVID-19/virology , RNA, Viral/genetics , Antibodies, Neutralizing/blood , Antibodies, Neutralizing/immunology , Antibodies, Viral/blood , Antibodies, Viral/immunology , Virus Shedding , Disease Reservoirs/virology , Female
12.
Infect Genet Evol ; 121: 105604, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38754756

ABSTRACT

Bats are known reservoirs of various emerging pathogens, and have recently been found to host a novel hantavirus, named Brno loanvirus (BRNV), from the Mammantavirinae subfamily (family Hantaviridae, order Bunyavirales). Here we report BRNV detection in bats from the urban area of Brno, Czech Republic in March 2022. Specifically, we uncovered a high prevalence of BRNV (8.8%, 5/57) among hibernating bats (Nyctalus noctula) in urban area, which poses a risk of human exposure. The positive bats included adult females (3/9 positive), a juvenile female (1/32 positive), and an adult male (1/6 positive). All 10 juvenile males were negative. We used RT-qPCR to quantify the BRNV RNA levels in various bat organs, which yielded positive results for viral RNA in organs, including the kidneys, heart, spleen, brain, liver, lung, and gut, and in body cavity fluid. Among all tested organs, the liver showed the highest levels of viral RNA in 4 out of 5 animals examined (average Ct value of 20.8 ± 7.4).


Subject(s)
Chiroptera , Animals , Czech Republic/epidemiology , Chiroptera/virology , Female , Male , Orthohantavirus/genetics , Orthohantavirus/isolation & purification , Orthohantavirus/classification , RNA, Viral/genetics , Phylogeny , Disease Reservoirs/virology , Hantavirus Infections/veterinary , Hantavirus Infections/epidemiology , Hantavirus Infections/virology
13.
Viruses ; 16(4)2024 03 27.
Article in English | MEDLINE | ID: mdl-38675857

ABSTRACT

The persistence of the latent viral reservoir is the main hurdle to curing HIV-1 infection. SIV infection of non-human primates (NHPs), namely Indian-origin rhesus macaques, is the most relevant and widely used animal model to evaluate therapies that seek to eradicate HIV-1. The utility of a model ultimately rests on how accurately it can recapitulate human disease, and while reservoirs in the NHP model behave quantitatively very similar to those of long-term suppressed persons with HIV-1 (PWH) in the most salient aspects, recent studies have uncovered key nuances at the clonotypic level that differentiate the two in qualitative terms. In this review, we will highlight differences relating to proviral intactness, clonotypic structure, and decay rate during ART between HIV-1 and SIV reservoirs and discuss the relevance of these distinctions in the interpretation of HIV-1 cure strategies. While these, to some degree, may reflect a unique biology of the virus or host, distinctions among the proviral landscape in SIV are likely to be shaped significantly by the condensed timeframe of NHP studies. ART is generally initiated earlier in the disease course, and animals are virologically suppressed for shorter periods before receiving interventions. Because these are experimental variables dictated by the investigator, we offer guidance on study design for cure-related studies performed in the NHP model. Finally, we highlight the case of GS-9620 (Vesatolimod), an antiviral TLR7 agonist tested in multiple independent pre-clinical studies in which virological outcomes may have been influenced by study-related variables.


Subject(s)
HIV Infections , HIV-1 , Simian Acquired Immunodeficiency Syndrome , Simian Immunodeficiency Virus , Virus Latency , Animals , Humans , Disease Models, Animal , Disease Reservoirs/virology , HIV Infections/virology , HIV Infections/drug therapy , HIV-1/genetics , HIV-1/drug effects , HIV-1/physiology , Macaca mulatta , Proviruses/genetics , Proviruses/physiology , Simian Acquired Immunodeficiency Syndrome/virology , Simian Acquired Immunodeficiency Syndrome/drug therapy , Simian Immunodeficiency Virus/genetics , Simian Immunodeficiency Virus/physiology , Viral Load , Virus Latency/drug effects
14.
Nat Commun ; 15(1): 3589, 2024 Apr 27.
Article in English | MEDLINE | ID: mdl-38678025

ABSTRACT

The black rat (Rattus rattus) is a globally invasive species that has been widely introduced across Africa. Within its invasive range in West Africa, R. rattus may compete with the native rodent Mastomys natalensis, the primary reservoir host of Lassa virus, a zoonotic pathogen that kills thousands annually. Here, we use rodent trapping data from Sierra Leone and Guinea to show that R. rattus presence reduces M. natalensis density within the human dwellings where Lassa virus exposure is most likely to occur. Further, we integrate infection data from M. natalensis to demonstrate that Lassa virus zoonotic spillover risk is lower at sites with R. rattus. While non-native species can have numerous negative effects on ecosystems, our results suggest that R. rattus invasion has the indirect benefit of decreasing zoonotic spillover of an endemic pathogen, with important implications for invasive species control across West Africa.


Subject(s)
Disease Reservoirs , Introduced Species , Lassa Fever , Lassa virus , Murinae , Zoonoses , Animals , Lassa virus/pathogenicity , Lassa virus/physiology , Lassa Fever/transmission , Lassa Fever/epidemiology , Lassa Fever/virology , Lassa Fever/veterinary , Disease Reservoirs/virology , Humans , Rats , Murinae/virology , Zoonoses/virology , Zoonoses/transmission , Zoonoses/epidemiology , Sierra Leone/epidemiology , Guinea/epidemiology , Ecosystem , Rodent Diseases/virology , Rodent Diseases/epidemiology , Rodent Diseases/transmission
15.
Viruses ; 16(4)2024 04 22.
Article in English | MEDLINE | ID: mdl-38675988

ABSTRACT

Sosuga virus (SOSV), a rare human pathogenic paramyxovirus, was first discovered in 2012 when a person became ill after working in South Sudan and Uganda. During an ecological investigation, several species of bats were sampled and tested for SOSV RNA and only one species, the Egyptian rousette bat (ERBs; Rousettus aegyptiacus), tested positive. Since that time, multiple other species have been sampled and ERBs in Uganda have continued to be the only species of bat positive for SOSV infection. Subsequent studies of ERBs with SOSV demonstrated that ERBs are a competent host for SOSV and shed this infectious virus while exhibiting only minor infection-associated pathology. Following the 2014 Ebola outbreak in West Africa, surveillance efforts focused on discovering reservoirs for zoonotic pathogens resulted in the capture and testing of many bat species. Here, SOSV RNA was detected by qRT-PCR only in ERBs captured in the Moyamba District of Sierra Leone in the central region of the country. These findings represent a substantial range extension from East Africa to West Africa for SOSV, suggesting that this paramyxovirus may occur in ERB populations throughout its sub-Saharan African range.


Subject(s)
Chiroptera , Animals , Chiroptera/virology , Sierra Leone/epidemiology , Paramyxoviridae Infections/veterinary , Paramyxoviridae Infections/virology , Paramyxoviridae Infections/epidemiology , RNA, Viral/genetics , Phylogeny , Disease Reservoirs/virology , Humans
16.
Front Cell Infect Microbiol ; 14: 1364002, 2024.
Article in English | MEDLINE | ID: mdl-38660490

ABSTRACT

The role of the oral microbiota in the overall health and in systemic diseases has gained more importance in the recent years, mainly due to the systemic effects that are mediated by the chronic inflammation caused by oral diseases, such as periodontitis, through the microbial communities of the mouth. The chronic infection by the human immunodeficiency virus (HIV) interacts at the tissue level (e.g. gut, genital tract, brain) to create reservoirs; the modulation of the gut microbiota by HIV infection is a good example of these interactions. The purpose of the present review is to assess the state of knowledge on the oral microbiota (microbiome, mycobiome and virome) of HIV-infected patients in comparison to that of HIV-negative individuals and to discuss the reciprocal influence of HIV infection and oral microbiota in patients with periodontitis on the potential establishment of a viral gingival reservoir. The influence of different clinical and biological parameters are reviewed including age, immune and viral status, potent antiretroviral therapies, smoking, infection of the airway and viral coinfections, all factors that can modulate the oral microbiota during HIV infection. The analysis of the literature proposed in this review indicates that the comparisons of the available studies are difficult due to their great heterogeneity. However, some important findings emerge: (i) the oral microbiota is less influenced than that of the gut during HIV infection, although some recurrent changes in the microbiome are identified in many studies; (ii) severe immunosuppression is correlated with altered microbiota and potent antiretroviral therapies correct partially these modifications; (iii) periodontitis constitutes a major factor of dysbiosis, which is exacerbated in HIV-infected patients; its pathogenesis can be described as a reciprocal reinforcement of the two conditions, where the local dysbiosis present in the periodontal pocket leads to inflammation, bacterial translocation and destruction of the supporting tissues, which in turn enhances an inflammatory environment that perpetuates the periodontitis cycle. With the objective of curing viral reservoirs of HIV-infected patients in the future years, it appears important to develop further researches aimed at defining whether the inflamed gingiva can serve of viral reservoir in HIV-infected patients with periodontitis.


Subject(s)
Gingiva , HIV Infections , Microbiota , Humans , HIV Infections/drug therapy , HIV Infections/microbiology , HIV Infections/complications , HIV Infections/virology , Gingiva/microbiology , Gingiva/virology , Mouth/microbiology , Mouth/virology , Disease Reservoirs/microbiology , Disease Reservoirs/virology , Periodontitis/microbiology , Periodontitis/virology , Virome , Dysbiosis/microbiology , Anti-Retroviral Agents/therapeutic use , HIV
17.
Future Microbiol ; 19(9): 841-856, 2024 Jun 12.
Article in English | MEDLINE | ID: mdl-38648093

ABSTRACT

The emergence of highly zoonotic viral infections has propelled bat research forward. The viral outbreaks including Hendra virus, Nipah virus, Marburg virus, Ebola virus, Rabies virus, Middle East respiratory syndrome coronavirus, SARS-CoV and the latest SARS-CoV-2 have been epidemiologically linked to various bat species. Bats possess unique immunological characteristics that allow them to serve as a potential viral reservoir. Bats are also known to protect themselves against viruses and maintain their immunity. Therefore, there is a need for in-depth understanding into bat-virus biology to unravel the major factors contributing to the coexistence and spread of viruses.


Bats are the most diverse mammalian order, with over 1400 species found worldwide. Studies on bats have revealed that they frequently carry and transmit multiple viruses. They are also known to recover from viral infections. Further, human interference and climatic changes in bats' native habitat have led to virus spillover events from bats to human populations, posing a serious public health risk. A deeper understanding of the coexistence of bats and viruses, as well as the mechanisms of disease transmission to humans, is required to minimize the risk of future viral outbreaks.


Subject(s)
Chiroptera , Disease Reservoirs , Chiroptera/virology , Chiroptera/immunology , Animals , Humans , Disease Reservoirs/virology , Virus Diseases/immunology , Virus Diseases/virology , Virus Diseases/veterinary , Viral Zoonoses/transmission , Viral Zoonoses/virology , SARS-CoV-2/immunology , COVID-19/immunology , COVID-19/virology , Viruses/immunology , Viruses/classification , Viruses/genetics , Zoonoses/virology , Zoonoses/transmission , Zoonoses/immunology
18.
Ecohealth ; 21(1): 94-111, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38372845

ABSTRACT

Ecological information on wildlife reservoirs is fundamental for research targeting prevention of zoonotic infectious disease, yet basic information is lacking for many species in global hotspots of disease emergence. We provide the first estimates of synchronicity, magnitude, and timing of seasonal birthing in Mops condylurus, a putative ebolavirus host, and a co-roosting species, Mops pumilus (formerly Chaerephon pumilus). We show that population-level synchronicity of M. condylurus birthing is wide (~ 8.5 weeks) and even wider in M. pumilus (> 11 weeks). This is predicted to promote the likelihood of filovirus persistence under conditions of bi-annual birthing (two births per year). Ecological features underlying the magnitude of the birth pulse-relative female abundance (higher than expected for M. condylurus and lower for M. pumilus, based on literature) and reproductive rate (lower than expected)-will have countering effects on birthing magnitude. Species-specific models are needed to interpret how identified birth pulse attributes may interact with other features of molossid ebolavirus ecology to influence infection dynamics. As a common feature of wildlife species, and a key driver of infection dynamics, detailed information on seasonal birthing will be fundamental for future research on these species and will be informative for bat-borne zoonoses generally.


Subject(s)
Chiroptera , Seasons , Animals , Chiroptera/virology , Female , Kenya/epidemiology , Disease Reservoirs/virology , Hemorrhagic Fever, Ebola/epidemiology , Ebolavirus , Parturition , Zoonoses/virology
20.
AIDS ; 38(8): 1120-1130, 2024 07 01.
Article in English | MEDLINE | ID: mdl-38224350

ABSTRACT

OBJECTIVE: The immunogenic nature of coronavirus disease 2019 (COVID-19) mRNA vaccines led to some initial concern that these could stimulate the HIV reservoir. We analyzed changes in plasma HIV loads (pVL) and reservoir size following COVID-19 mRNA vaccination in 62 people with HIV (PWH) receiving antiretroviral therapy (ART), and analyzed province-wide trends in pVL before and after the mass vaccination campaign. DESIGN: Longitudinal observational cohort and province-wide analysis. METHODS: Sixty-two participants were sampled prevaccination, and one month after their first and second COVID-19 immunizations. Vaccine-induced anti-SARS-CoV-2-Spike antibodies in serum were measured using the Roche Elecsys Anti-S assay. HIV reservoirs were quantified using the intact proviral DNA assay; pVL were measured using the cobas 6800 (lower limit of quantification: 20 copies/ml). The province-wide analysis included all 290 401 pVL performed in British Columbia, Canada between 2012 and 2022. RESULTS: Prevaccination, the median intact reservoir size was 77 [interquartile range (IQR): 20-204] HIV copies/million CD4 + T-cells, compared to 74 (IQR: 27-212) and 65 (IQR: 22-174) postfirst and -second dose, respectively (all comparisons P > 0.07). Prevaccination, 82% of participants had pVL <20 copies/ml (max: 110 copies/ml), compared to 79% postfirst dose (max: 183 copies/ml) and 85% postsecond dose (max: 79 copies/ml) ( P  > 0.4). There was no evidence that the magnitude of the vaccine-elicited anti-SARS-CoV-2-Spike immune response influenced pVL nor changes in reservoir size ( P  > 0.6). We found no evidence linking the COVID-19 mass vaccination campaign to population-level increases in detectable pVL frequency among all PWH in the province, nor among those who maintained pVL suppression on ART. CONCLUSION: We found no evidence that COVID-19 mRNA vaccines induced changes in HIV reservoir size nor plasma viremia.


Subject(s)
COVID-19 Vaccines , COVID-19 , HIV Infections , SARS-CoV-2 , Viral Load , Viremia , Humans , HIV Infections/drug therapy , HIV Infections/prevention & control , Male , Female , Middle Aged , COVID-19 Vaccines/immunology , COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Adult , SARS-CoV-2/immunology , Longitudinal Studies , Antibodies, Viral/blood , British Columbia , Vaccination , Disease Reservoirs/virology
SELECTION OF CITATIONS
SEARCH DETAIL